12-month outcomes of dolutegravir (DTG) plus lamivudine (3TC) in ART-naive and pre-treated people living with HIV in Germany: real-world data from the German URBAN cohortS. Scholten,S. Noe,C. Wyen,D. Beer,N. Postel, O. Degen,R. Pauli,H. Hillenbrand,B. Westermayer, K. M. Dymek, J. ScherzerHIV MEDICINE（2021）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
